3656 results for «335»

Filter By

3656 results

Rapid-fire - Complex procedure in TAVI - Part 2

18 Feb 2024 – From PCR Tokyo Valves 2024

In the second part of this rapid-fire session, we continue to focus on complex cases that might arise during TAVI, such as a case of prosthetic aortic valve endocarditis resulting in cardiogenic shock,  treatment of severe AR after infective endocarditis, and more!

Rapid-fire - Complications of Mitral TEER - Part 2

18 Feb 2024 – From PCR Tokyo Valves 2024

Gain valuable insights into the possible complications of Mitral Transcatheter Edge-to-Edge Repair (TEER) in the second part of this session rapid-fire submission cases [in Japanese].

Nightmares in TAVI: sharing solutions together

18 Feb 2024 – From PCR Tokyo Valves 2024

Consult this session to learn more about bailout techniques for TAVI during uncommon complications, such as late coronary obstruction post-TAVI, a migrated self-expandable valve, or a C-tab induced iatrogenic thoracic aortic dissection after Evolut FX implantation.

Imaging for aortic valve disease

18 Feb 2024 – From PCR Tokyo Valves 2024

Learn about imaging of the aortic valve system in order to better deal with aortic valve disease. Through this series of cases, explore topics such as the impact of implantation depth relative to membranous septum on TAVI outcomes, delve into a meta-analysis exploring the outcomes of...

Rapid-fire - Pulmonary and tricuspid valve implantation

18 Feb 2024 – From PCR Tokyo Valves 2024

In this series of rapid-fire case submissions, gain insight into pulmonary and tricuspid valve implantation. This session explores cases such as a pulmonary valve-in-valve procedure, dealing with tissue valve degeneration, and valve implantation in a calcified RV-PA conduit.

Rapid-fire - Pulmonary and tricuspid valve implantation

Rapid-fire - Transcatheter interventions for tailed mitral valve prosthesis

18 Feb 2024 – From PCR Tokyo Valves 2024

This session of rapid-fire submitted cases focuses on transcatheter interventions for tailed mitral valve prosthesis. Learn about unusual solutions, such a reversed loop and parallel wiring to close crescent mitral paravalvular leak, base-to-tip LAMPOON and IABP during a successful mitral valve-in-valve, and more!

Rapid-fire - Transcatheter interventions for tailed mitral valve prosthesis

Rapid-fire - Bailout in SHD

17 Feb 2024 – From PCR Tokyo Valves 2024

Gain valuable insights into the bailout techniques in structural heart disease intervention in this session of rapid-fire submission cases (in Japanese).

Complex diagnosis

17 Feb 2024 – From PCR Tokyo Valves 2024

Gain valuable insights in how to deal with complex diagnoses in this session of rapid-fire submissions cases [in Japanese].

Legal notice

19 Oct 2018

Updated - August 22nd, 2023

AsiaPCR 2018: General Terms and conditions of sale

Before you register for the Course, make sure you are familiar with our General Terms and conditions of sale.

MASTER-DAPT: “the MASTER of high-bleeding risk trials”

28 Aug 2021

Marco Valgimigli (Lugano, Switzerland) presented the results of the MASTER DAPT trial on Saturday, August 28, in a Hot Line session of the ESC Congress 2021. Luis G. Ortega-Paz provides his PICOT & SWOT analysis of this study.

Luis Ortega-Paz

Author

Luis Ortega-Paz
ESC Congress 2021 - MASTER-DAPT : “the MASTER of high-bleeding risk trials”

ALL-RISE: A large-scale, global randomized trial of coronary physiology derived from conventional angiography compared with an invasive pressure wire-based approach to guide PCI

28 Mar 2026

Mirvat Al Asnag provides her take on the ALL-RISE randomised trial presented by Ajay J. Kirtane at ACC.26 in New Orleans.

Dr. Mirvat Alasnag

Author

Mirvat Alasnag
A large-scale, global randomized trial of coronary physiology derived from conventional angiography compared with an invasive pressure wire-based approach to guide percutaneous coronary intervention

Europa Group's General Terms and Conditions of Sale

12 Apr 2024

Ref 02P - Updated June 2024

Harmonising optimal strategy for treatment of coronary artery diseases – bleeding risk: HOST-BR

29 Mar 2025

Daniele Giacoppo and Nicola Ammirabile provide their take on the main results of the HOST-BR trial, presented by Hyo-Soo Kim at ACC.25 in Chicago.

Nicola Ammirabile

Author

Nicola Ammirabile
Daniele Giacoppo

Author

Daniele Giacoppo
Harmonising optimal strategy for treatment of coronary artery diseases – bleeding risk: HOST-BR

The AQUATIC trial: Assessment of quitting versus using aspirin therapy in patients with stabilized coronary artery disease after stenting who require long-term oral anticoagulation

01 Sep 2025

Chiara De Biase provides her take on the results of AQUATIC presented by Martine Gilard at ESC Congress 2025 in Madrid.

Author

Chiara De Biase
The AQUATIC trial [Assessment of quitting versus using aspirin therapy in patients with stabilized coronary artery disease after stenting who require long-term oral anticoagulation: Rationale for and design of the AQUATIC double-blind randomized trial]

NEO-MINDSET: Early withdrawal of aspirin after percutaneous coronary intervention for acute coronary syndrome

02 Sep 2025

Daniele Giacoppo reports and provides his perspective on the main results of the ambitious NEOMINDSET trial, presented by Pedro Lemos from the Hospital Israelita Albert Einstein, São Paulo, Brazil, during a Late Breaking Trials session at the ESC Congress 2025 in Madrid, and simultaneously published in the New...

Daniele Giacoppo

Author

Daniele Giacoppo
NEO-MINDSET: Early withdrawal of aspirin after percutaneous coronary intervention for acute coronary syndrome
Didn’t find what you were looking for?